ClinicalTrials.gg
CompletedNCT05188898Updated Apr 29, 2024

Treatment of Intraosseous Periodontal Defects With Hyaluronic Acid

An interventional study of MINSD and Hyaluronic acid and MINSD in Periodontal Bone Loss and Periodontal Pocket, sponsored by Federico II University. Completed at 1 site in Italy. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-29.

Sponsored by Federico II University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of the present investigation will be evaluate the healing of periodontal intraosseous defects following Minimally Invasive Non Surgical Debridement (MINSD) and application of a hyaluronic acid-based gel, compared to MINSD alone.

A total of 22 patients will be enrolled, selected by inclusion and exclusion criteria and randomly divided in two groups: hyaluronic acid group (HA) and no-hyaluronic acid group (No-HA).

Read the detailed description

The objective of the study will be compare the healing of periodontal intraosseous defects following treatment with Minimally Invasive Non Surgical Debridement (MINSD) and application of hyaluronic acid (HA) compared to MINSD alone.

Twenty-two patients with intraosseous periodontal defects will be randomly assigned to treatment with MINSD and application of a hyaluronic acid-based gel (HA Group) or MINSD alone (No-HA Group).

Primary outcome will be "Probing Depth" (PD), while the secondary outcomes will be "Clinical Attachment Level" (CAL) gain, "Gingival Recession" (GR) and "Radiographic Defect Angle" (RDA).

After local anesthesia, in HA group MINSD will be performed using an ultrasonic scaler with fine tips and micro-curette; then, a hyaluronic acid-based gel will be applied to the intraosseous periodontal pockets.

In the No-HA group, only subgingival mechanical debridement (MINSD) will be performed with an ultrasonic scaler with fine tips and micro-curette.

Finally, a polishing paste will be applied to the supra-gingival level in both groups using a rubber cup. Patients of both groups will be recalled every month for professional oral hygiene and, after 6 months, all measurements will be repeated and the final evaluation will be carried out.

02

Conditions studied

  • Periodontal Bone Loss
  • Periodontal Pocket

Keywords

  • Hyaluronic Acid
  • Periodontal therapy
  • Periodontal Bone Loss
  • Intraosseous Bone Defect
03

In context

Alveolar Bone Loss

304 studies on the registry are indexed under Alveolar Bone Loss; 77 are open to participants now.

This study's enrollment of 22 is below the median of 25 across 261 interventional studies indexed under Alveolar Bone Loss.

Browse Alveolar Bone Loss studies →

Lead sponsor

Federico II University is the lead sponsor of 366 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with periodontitis;
  • Age ≥ 18 years old;
  • Presence of at least 10 teeth per arch;
  • Presence of at least two teeth with Probing Depth (PD) ≥ 5 mm per quadrant;
  • Presence of at least one intraosseous pocket;
  • Single-rooted and multi-rooted teeth.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic diseases;
  • Prolonged antibiotic or anti-inflammatory treatment within 4 weeks prior to periodontal therapy;
  • Pregnant or lactating;
  • Tobacco smokers (≥ 10 cigarettes per day);
  • Multi-rooted teeth with furcation involvement;
  • Third molars.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Hyaluronic acid Group

    Hyaluronic acid gel will be applied in intraosseous periodontal defects, after Minimally Invasive Non Surgical Debridement (MINSD)

    Other: MINSD and Hyaluronic acid

  • Active comparator
    No-hyaluronic acid Group

    Only Minimally Invasive Non Surgical Debridement (MINSD) will be performed

    Other: MINSD

Interventions

  • OtherMINSD and Hyaluronic acid

    After local anesthesia, MINSD will be performed using an ultrasonic scaler with fine tips and micro-curette; then, a hyaluronic acid-based gel will be applied to the intraosseous periodontal pockets.

  • OtherMINSD

    Only subgingival mechanical debridement (MINSD) will be performed with an ultrasonic scaler with fine tips and micro-curette.

06

What researchers measure

Primary outcomes

  1. Change of Probing Depth (PD) (millimeters)

    Distance from the gingival margin to the bottom of the pocket

    Time frame: baseline and 6 months after periodontal therapy

Secondary outcomes

  1. Change of Clinical Attachment Level (CAL) gain (millimeters)

    Distance from the Cement Enamel Junction (CEJ) to the bottom of the pocket

    Time frame: baseline and 6 months after periodontal therapy

  2. Change of Gingival Recession (GR) (millimeters)

    Distance from gingival margin to the cementoenamel junction

    Time frame: baseline and 6 months after periodontal therapy

  3. Change of Radiographic Defect Angle (RDA) (grade °)

    Radiographic intraosseous angle

    Time frame: baseline and 6 months after periodontal therapy

07

Study locations

1 site
  • University of Naples Federico II
    Naples, 80131, Italy
08

References and documents

Publications

  • Iorio-Siciliano V, Blasi A, Mauriello L, Salvi GE, Ramaglia L, Sculean A. Non-Surgical Treatment of Moderate Periodontal Intrabony Defects With Adjunctive Cross-Linked Hyaluronic Acid: A Single-Blinded Randomized Controlled Clinical Trial. J Clin Periodontol. 2025 Feb;52(2):310-322. doi: 10.1111/jcpe.14078. Epub 2024 Oct 14. PubMed 39402910 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05188898
Responsible party
Luca Ramaglia (Clinical Professor, Federico II University) — Principal investigator
First posted
Jan 12, 2022
Start date
Jan 12, 2022
Primary completion
Mar 8, 2023
Completion
Mar 8, 2023
Last update
Apr 29, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion